Bipolar Disorder Treatment Medications

Medications Used to Treat Bipolar Disorder
​Bipolar disorder (BD) requires a comprehensive treatment approach, often involving a combination of mood stabilizers, antipsychotics, antidepressants, and anticonvulsants. Below is a list of commonly prescribed medications for BD, with brief descriptions and their clinical applications:

1. Lithium

• Class: Mood Stabilizer
• Mechanism of Action: Lithium is believed to alter sodium transport across cell membranes in the brain, affecting neurotransmitter balance, including serotonin and dopamine.
• Indications: Primarily used to treat and prevent mania and depression in Bipolar I disorder. It is also used for maintenance therapy to reduce the frequency of mood swings.
• Side Effects: Tremors, weight gain, cognitive dulling, thyroid dysfunction, kidney issues, and potential for toxicity (monitoring required).
• Efficacy: Effective in reducing both manic and depressive episodes in bipolar disorder and lowering the risk of suicide.
• Sources: Cipriani et al., The Lancet, 2013; Muench & Hamer, 2010.

2. Valproate (Depakote)

• Class: Anticonvulsant/Mood Stabilizer
• Mechanism of Action: Increases GABA activity and inhibits glutamate, which helps balance mood fluctuations.
• Indications: Used for acute mania and for maintenance therapy in bipolar disorder. It is especially useful when lithium is not effective or tolerated.
• Side Effects: Weight gain, sedation, liver toxicity (requires monitoring), and gastrointestinal distress.
• Efficacy: Effective for controlling manic episodes but less effective for depressive episodes.
• Sources: Bowden et al., The Journal of Clinical Psychiatry, 2000.

3. Lamotrigine (Lamictal)

• Class: Anticonvulsant/Mood Stabilizer
• Mechanism of Action: Modulates sodium channels, reducing glutamate release, which helps stabilize mood.
• Indications: Primarily used to prevent depressive episodes in bipolar disorder and as a maintenance medication.
• Side Effects: Rash (rare, but serious—can develop into Stevens-Johnson syndrome), dizziness, headache, nausea.
• Efficacy: Effective in preventing depressive episodes but not as effective in treating acute manic episodes.
• Sources: Ketter et al., Bipolar Disorders, 2008; Calabrese et al., The Lancet, 2004.

4. Atypical AntipsychoticsThese drugs are often prescribed in combination with mood stabilizers for acute mania or mixed episodes and as maintenance therapy.
Olanzapine (Zyprexa)

• Class: Atypical Antipsychotic
• Mechanism of Action: Blocks dopamine D2 and serotonin 5-HT2 receptors, helping to stabilize mood and reduce psychotic symptoms.
• Indications: Used in acute mania and maintenance of bipolar disorder.
• Side Effects: Weight gain, sedation, metabolic syndrome, and extrapyramidal symptoms (EPS).
• Efficacy: Effective for both acute mania and as a long-term maintenance treatment.
• Sources: Olfson et al., JAMA Psychiatry, 2014.

Quetiapine (Seroquel)

• Class: Atypical Antipsychotic
• Mechanism of Action: Like olanzapine, quetiapine blocks serotonin and dopamine receptors, with a sedative effect.
• Indications: Approved for both acute mania and depressive episodes in bipolar disorder, as well as for maintenance therapy.
• Side Effects: Sedation, weight gain, and metabolic side effects.
• Efficacy: Particularly effective for bipolar depression and mania, with a good safety profile for long-term use.
• Sources: Vieta et al., The Lancet Psychiatry, 2018.

Aripiprazole (Abilify)

• Class: Atypical Antipsychotic
• Mechanism of Action: Dopamine system stabilizer, acting as a partial agonist at dopamine D2 receptors, reducing both mania and depression.
• Indications: Used for acute mania and maintenance treatment in bipolar disorder.
• Side Effects: Weight gain, sedation, restlessness (akathisia).
• Efficacy: Good for both mania and maintenance, with fewer metabolic side effects than some other atypical antipsychotics.
• Sources: Olfson et al., JAMA Psychiatry, 2014.

Risperidone (Risperdal)

• Class: Atypical Antipsychotic
• Mechanism of Action: Risperidone blocks dopamine D2 and serotonin 5-HT2 receptors. It helps reduce manic symptoms and prevent psychosis.
• Indications: Used to treat acute mania and maintenance in Bipolar I disorder.
• Side Effects: Weight gain, sedation, EPS (including tremors, rigidity), and potential for metabolic side effects.
• Efficacy: Effective for acute mania and maintenance therapy. It is considered an option for individuals who may not respond well to other antipsychotics.
• Sources: Muench & Hunter, J Clin Psychopharmacol, 2009; Tohen et al., The Journal of Clinical Psychiatry, 2007.

5. Antidepressants
Antidepressants are used in bipolar depression but are typically combined with a mood stabilizer or antipsychotic to avoid triggering a manic episode.
Selective Serotonin Reuptake Inhibitors (SSRIs)

• Examples: Fluoxetine (Prozac), Sertraline (Zoloft)
• Class: Antidepressants
• Mechanism of Action: Increase serotonin levels by inhibiting its reuptake.
• Indications: Prescribed for bipolar depression, often in combination with a mood stabilizer.
• Side Effects: Sexual dysfunction, weight gain, insomnia.
• Efficacy: Effective for managing depressive episodes but must be used cautiously with mood stabilizers to avoid inducing mania.
• Sources: Fountoulakis et al., CNS Spectrums, 2015.

6. Carbamazepine (Tegretol)

• Class: Anticonvulsant/Mood Stabilizer
• Mechanism of Action: Inhibits voltage-gated sodium channels, stabilizing mood.
• Indications: Used for acute mania and as a maintenance treatment in bipolar disorder, particularly in those who do not respond to lithium or valproate.
• Side Effects: Drowsiness, dizziness, rash, and liver dysfunction (requires regular monitoring).
• Efficacy: Effective for mania but less effective for bipolar depression.
• Sources: Bowden et al., The Journal of Clinical Psychiatry, 2000.

7. Lumateperone (Caplyta) is an atypical antipsychotic medication approved by the FDA for the treatment of bipolar depression in adults with bipolar I or bipolar II disorder. It is also approved for schizophrenia treatment.
Key Features:

• Mechanism of Action: Lumateperone works by modulating serotonin, dopamine, and glutamate systems in the brain. It acts as a serotonin receptor antagonist, dopamine receptor modulator, and affects glutamatergic signaling.
• Indications:
  • Depressive episodes in bipolar I and II disorders (alone or with lithium or valproate).
  • Schizophrenia.
• Dosing: Typically prescribed as 42 mg once daily, taken with food.
• Side Effects: Common side effects include drowsiness, dry mouth, dizziness, and nausea. It has a favorable metabolic profile compared to other antipsychotics, with lower risks of weight gain and metabolic syndrome.
• Advantages:
  • Effective for bipolar depression.
  • Minimal sedative effects.
  • Lower risk of metabolic and cardiovascular side effects compared to other antipsychotics.

Lumateperone offers an alternative for individuals who struggle with the side effects of traditional treatments or need targeted management for depressive episodes. Always consult with a healthcare provider to determine if this medication is suitable for your specific needs.

8. Cariprazine (Vraylar) is an atypical antipsychotic medication approved by the FDA for treating various symptoms associated with mental health conditions, including bipolar disorder, schizophrenia, and major depressive disorder (as an adjunct therapy).
Key Features:

• Mechanism of Action:
  Cariprazine acts as a partial agonist at dopamine D2 and D3 receptors, with a preference for D3 receptors. This helps regulate dopamine activity, which plays a key role in mood, motivation, and cognition. It also affects serotonin receptors, contributing to its antidepressant and mood-stabilizing effects.
• Indications:
  • Manic or mixed episodes associated with bipolar I disorder.
  • Depressive episodes in bipolar I disorder (bipolar depression).
  • Maintenance treatment for bipolar I disorder.
  • Schizophrenia treatment in adults.
  • Adjunct therapy for major depressive disorder (MDD).
  • Dosing:
    The dose varies depending on the condition but typically ranges from 1.5 mg to 6 mg per day, taken orally. It is generally started at a low dose and adjusted based on the individual's response.
  • Side Effects:
    Common side effects include nausea, restlessness (akathisia), sleepiness, dizziness, and indigestion. Cariprazine has a long half-life, so some side effects may appear after prolonged use.
  • Advantages:
    • Effective for both manic and depressive episodes in bipolar disorder.
    • May improve cognitive and negative symptoms in schizophrenia.
    • Offers a unique option for individuals with partial dopamine dysregulation.
• Cariprazine provides a versatile treatment option for bipolar disorder and schizophrenia, particularly for those who may benefit from targeted dopamine modulation. 

9. Brexpiprazole (Rexulti) is an atypical antipsychotic medication approved by the FDA for the treatment of schizophrenia and as an adjunct therapy for major depressive disorder (MDD) in adults. It is also being explored for other uses, such as bipolar disorder and agitation associated with dementia.
Key Features:

• Mechanism of Action:
  Brexpiprazole acts as a partial agonist at dopamine D2 receptors and serotonin 5-HT1A receptors, helping balance dopamine and serotonin activity in the brain. It also works as an antagonist at serotonin 5-HT2A receptors. This dual action helps regulate mood, cognition, and emotional responses.
• Indications:
  • Schizophrenia: Reduces symptoms like hallucinations, delusions, and disorganized thinking.
  • Major Depressive Disorder (MDD): Used in combination with antidepressants for individuals who do not achieve full symptom relief with antidepressants alone.
• Dosing:
  • For MDD, the recommended starting dose is 0.5 mg to 1 mg once daily, adjusted up to a maximum of 3 mg daily.
  • For schizophrenia, the usual dose ranges from 1 mg to 4 mg once daily.
    It is taken orally, with or without food.
• Side Effects:
  Common side effects include weight gain, restlessness (akathisia), drowsiness, nausea, and fatigue. Serious side effects, though rare, may include metabolic changes, tardive dyskinesia, or increased risk of suicidal thoughts in younger individuals.
• Advantages:
  • Provides effective symptom relief for both mood and psychotic disorders.
  • Has a favorable tolerability profile compared to some other atypical antipsychotics.
  • May have fewer side effects related to sedation and metabolic disturbances.

Brexpiprazole is a versatile treatment option, particularly for individuals needing adjunctive therapy for depression or effective management of schizophrenia. As with all antipsychotics, it should be prescribed and monitored by a healthcare professional.

10. Lurasidone (Latuda) is an atypical antipsychotic medication approved by the FDA for the treatment of schizophrenia and bipolar depression (depressive episodes associated with bipolar I disorder) in adults and adolescents.
Key Features:

• Mechanism of Action:
  Lurasidone works by modulating activity at serotonin (5-HT2A) and dopamine (D2) receptors, helping balance neurotransmitter activity in the brain. It also has some activity at other serotonin receptors, which may contribute to its antidepressant effects.
• Indications:
  • Schizophrenia: Reduces symptoms like hallucinations, delusions, and disorganized thinking.
  • Bipolar Depression: Treats depressive episodes in bipolar I disorder, either as monotherapy or in combination with mood stabilizers like lithium or valproate.
• Dosing:
  • For schizophrenia, the typical dose ranges from 40 mg to 160 mg once daily.
  • For bipolar depression, doses range from 20 mg to 120 mg once daily.
    It is taken orally and should be consumed with food (at least 350 calories) for optimal absorption.
• Side Effects:
  Common side effects include nausea, drowsiness, restlessness (akathisia), and weight gain. It has a relatively low risk of metabolic side effects (e.g., diabetes, weight gain) compared to other antipsychotics. Serious side effects may include tardive dyskinesia or neuroleptic malignant syndrome, though these are rare.
• Advantages:
  • Effective for depressive episodes in bipolar I disorder.
  • Low metabolic risk profile.
  • Approved for adolescents (10–17 years) with bipolar depression, making it a unique option for this age group.

Lurasidone is a well-tolerated option for managing mood and psychotic disorders, particularly for those needing a low-risk metabolic profile.

11. Olanzapine/Samidorphan (Lybalvi) is a combination medication approved by the FDA for the treatment of schizophrenia and bipolar I disorder, including manic, mixed, or maintenance episodes. It combines olanzapine, an atypical antipsychotic, with samidorphan, an opioid receptor antagonist.
Key Features:

• Mechanism of Action:
  • Olanzapine: Modulates dopamine and serotonin activity in the brain, helping to stabilize mood, reduce psychosis, and improve emotional regulation.
  • Samidorphan: Reduces the risk of weight gain and metabolic issues associated with olanzapine by counteracting some of its effects on appetite and metabolism.
• Indications:
  • Treatment of schizophrenia in adults.
  • Treatment of bipolar I disorder, including manic or mixed episodes and as a maintenance therapy.
• Dosing:
  Lybalvi is taken once daily, with doses of olanzapine ranging from 5 mg to 20 mg and samidorphan at a fixed dose of 10 mg. It can be taken with or without food.
• Side Effects:
  Common side effects include drowsiness, dry mouth, increased appetite, and fatigue. While it reduces the risk of weight gain compared to olanzapine alone, some weight gain is still possible. Serious side effects may include tardive dyskinesia, neuroleptic malignant syndrome, or increased blood sugar levels.
• Advantages:
  • Maintains the efficacy of olanzapine while mitigating some of its metabolic side effects.
  • Useful for individuals requiring long-term treatment who are concerned about weight gain or metabolic risks.
  • Provides effective symptom control for both schizophrenia and bipolar I disorder.

Lybalvi offers a novel approach by addressing a common side effect of antipsychotics, making it a valuable option for individuals seeking effective treatment with fewer metabolic concerns. 

Summary The treatment of bipolar disorder often involves a combination of mood stabilizers (e.g., lithium, valproate, lamotrigine), antipsychotics (e.g., olanzapine, quetiapine, aripiprazole), and antidepressants (e.g., SSRIs), each targeting different aspects of the disorder. The goal is to stabilize mood, reduce symptoms, and prevent relapse. The choice of medication depends on the specific type of bipolar disorder, the patient's symptoms, and their response to treatment.